L0909 is an HCV inhibitor with an EC50 of 0.022 µM. L0909 blocks HCV replication by inhibiting E1-mediated viral entry. L0909 exhibits sensitivity to clinical resistant HCV mutants. L0909 displays synergistic effects with clinical HCV drugs. L0909 can be used for the research of hepatitis c virus (HCV) infection[1].
Molecular Weight:
411.97
CAS Number:
[2085271-43-6]
Formula:
C23H30ClN5
Target:
HCV
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
